Omixon Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 55
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $1.5M
Latest Deal Amount
  • Investors
  • 8

Omixon General Information

Description

Developer of genetics and molecular diagnostics products intended to be used in transplantation. The company's products provide laboratory reagents and software to determine human leukocyte antigen (HLA) genotypes based on next-generation sequencing, enabling clinical labs with diagnostic products to improve patient outcomes.

Contact Information

Website
www.omixon.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
  • H-1117
  • Fehérvári Avenue 50-52.
  • Budapest, 1117
  • Hungary
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Omixon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 15-Dec-2016 $1.5M 00.000 Completed Generating Revenue/Not Profitable
4. Early Stage VC 17-Nov-2015 00.000 00.000 Completed Generating Revenue/Not Profitable
3. Early Stage VC 14-May-2014 00.000 Completed Generating Revenue/Not Profitable
2. Grant 09-May-2014 $450.12 $1.73M Completed Startup
1. Early Stage VC (Series A) 31-May-2012 $1.73M $1.73M Completed Startup
To view Omixon’s complete valuation and funding history, request access »

Omixon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of genetics and molecular diagnostics products intended to be used in transplantation. The company's products
Biotechnology
Budapest, Hungary
55 As of 2020
00.000
0000000000 0 00.000

00000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
0000000000 000000000
Cambridge, MA
0000 As of 0000
00000
0.000 0000-00-00
00000000000

00000000

nderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupid
0000000000 000000000
Fremont, CA
000 As of 0000
000
000000000000 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Omixon Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Cambridge, MA 0000 00000 00000000000
00000000 000000000 Formerly PE-Backed Fremont, CA 000 000 000000000000 000
0000000 0000000000 Corporate Backed or Acquired Carlsbad, CA 000 0000 000000&0 0000
00000 Private Equity-Backed Utrecht, Netherlands 00 0000000 0000
00000000 Pending Transaction (M&A) Irvine, CA 00 000.00 000000000 000.00
You’re viewing 5 of 21 competitors. Get the full list »

Omixon Executive Team (9)

Name Title Board Seat Contact Info
Attila Berces Ph.D Founder, Chief Executive Officer & Chairman
Judit Kósa Chief Financial Officer
Zoltán Simon Chief Operating Officer & Managing Director
Elmar Schilling Ph.D Chief Technology Officer
Gregory Werner Vice President of Commercial Operations
You’re viewing 5 of 9 executive team members. Get the full list »

Omixon Board Members (7)

Name Representing Role Since
Alexander Drijver Self Advisory Board Member 000 0000
Attila Berces Ph.D Omixon Founder, Chief Executive Officer & Chairman 000 0000
Attila Varkonyi Ph.D Self Board Member 000 0000
Dimitri Monos Omixon Board Member & Chairman of the Scientific Advisory Board 000 0000
Marton Szoke Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Omixon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Omixon Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FastVentures Other Minority 000 0000 000000 0
Futuremed Health Care Products Corporation Minority 000 0000 000000 0
Lochlomond Holding Corporation Minority 000 0000 000000 0
Zoltán Tóth Angel (individual) Minority 000 0000 000000 0
Attila Varkonyi Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »